Steven Cohen Forte Biosciences, Inc. Call Options Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FBRX
# of Institutions
33Shares Held
19MCall Options Held
3.1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$20.8 Million0.49% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$18.7 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$17.1 Million0.05% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$11.7 Million1.15% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$10.6 Million0.0% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $117M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.